For the first time, a clinical study has identified how CBD alters brain function in ways that may correlate with improvement in psychosis. “A dramatic change toward healthy … Continue reading How CBD alters brain function to improve psychosis; first-ever study
Canaccord Genuity Growth Corp. (CGG) yesterday provided an update on its agreement with Columbia Care, a leading medical cannabis company in the United States.
CGG has obtained approval to extend the Escrow Release Deadline, as per an amendment of the subscription receipt agreement terms. Continue reading Escrow-release deadline extended for Canaccord deal with Columbia Care
Several studies on cannabis dependance & withdrawal, registered and completed as far back as 2013, were updated yesterday and today. Updated records show Jan 14 or 15 as last date the clinical trial met “Quality Control” criteria. Continue reading Multiple clinical-trial records on negative aspects of cannabis were updated this week.
CannTrust investing approx. CAD $6 million for 20% stake in Australian company Cannatrek. Continue reading CannTrust stakes claim in Australia
Inhaling cannabis makes for easier breathing, because it dilates – or opens up – the airways in the lungs, according to a 1973 study published in New England Journal of Medicine.
Continue reading Breathing easier. Scientists from 1973 already knew that inhaling cannabis could open up airways in the lungs.
Spanish researchers, with @tilray support, are hoping a cocktail of THC, CBD and chemo drug TMZ can shrink brain-cancer tumours and increase survival rates for patients suffering a brain cancer called glioblastoma multiforme. Continue reading UPDATE: Tilray-sponsored brain-cancer study in Spain
Researchers have discovered that cannabis is frequently used to alleviate diarrhea, abdominal pain, and loss of appetite caused by inflammatory bowel disease.
Several clinical trials are planned or underway to assess the effectiveness of THC and CBD in treating these conditions, such a Crohn’s and colitis. Continue reading Can THC treat inflammatory bowel disease?
Large clinical trial – King’s College London – seeks to affirm CBD as a treatment for psychosis..
“CBD has emerged as a promising candidate as it displays anti-anxiety and anti-psychotic like properties in animals and humans.” Continue reading Clinical trial in UK aims to confirm CBD as treatment for psychosis
Drug company earning multi-millions on MS med containing only 2 ingredients – THC and CBD ready to launch epilepsy drug this fall & now racing to develop CBD drugs for schizophrenia, #autism & other hard-to treat diseases. Continue reading GWPH studying CBD for schizophrenia & other hard-to-treat diseases
First CBD and THC company in Italy planned as @MaricannInc partners with Italian producer. Centre of excellence for cannabis products also in the works. #cannabis Continue reading First CBD & THC company in Italy; Maricann partners with Italian producer